cephalosporin c has been researched along with Disbacteriosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bogár, L; Németh, M; Rozanovic, M; Ternák, G | 1 |
Shi, CY; Wang, JF; Ying, HZ | 1 |
Deng, J; Duan, Z; Fan, D; Zhang, M; Zhao, J; Zhu, C | 1 |
Bayjanov, JR; Bonten, MJ; Hendrickx, AP; Kemperman, H; Paganelli, FL; Rogers, MR; Top, J; Willems, RJ | 1 |
Gurevich, KG; Shulakova, OA; Zyryanov, SK | 1 |
Atkinson, A; Bernasconi, OJ; Donà, V; Endimiani, A; Furrer, H; Hauser, C; Perreten, V; Pires, J; Rauch, A; Tinguely, R | 1 |
6 other study(ies) available for cephalosporin c and Disbacteriosis
Article | Year |
---|---|
Antibiotic Consumption Patterns in European Countries Might Be Associated with the Prevalence of Type 1 and 2 Diabetes.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dysbiosis; Europe; Humans; Penicillins; Prevalence; Quinolones; Tetracyclines | 2022 |
Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice.
Topics: Animals; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cephalosporins; Dysbiosis; Inflammation; Mice; Streptococcus pneumoniae | 2022 |
The protective effect of protopanaxatriol-type saponin on intestinal health in antibiotic-treated mice.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Body Weight; Cephalosporins; Colon; Cytokines; Dysbiosis; Fatty Acids, Volatile; Feces; Gastrointestinal Microbiome; Inflammation; Intestines; Male; Mice; Mice, Inbred C57BL; Models, Animal; Occludin; Protective Agents; Receptors, G-Protein-Coupled; Sapogenins; Saponins; Tight Junction Proteins; Zonula Occludens-1 Protein | 2019 |
Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
Topics: Agglutination; Animals; Anti-Bacterial Agents; Cadherins; Calcium; Cephalosporins; Drug Resistance, Multiple, Bacterial; Dysbiosis; Enterococcus faecium; Feces; Female; Immunoglobulin A, Secretory; Intestinal Mucosa; Intestines; Mice; Microbiota; Mucin-2 | 2015 |
[OFF-LABEL DRUG USAGE IN THE TREATMENT OF URINARY TRACT INFECTION OF NEWBORNS].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Hypersensitivity; Drug Labeling; Dysbiosis; Female; Humans; Infant; Infant, Newborn; Length of Stay; Macrolides; Male; Moscow; Off-Label Use; Sulfonamides; Urinary Tract Infections | 2015 |
Intestinal colonisation with extended-spectrum cephalosporin- and colistin-resistant Enterobacteriaceae in HIV-positive individuals in Switzerland: molecular features and risk factors.
Topics: Anti-Bacterial Agents; beta-Lactamases; CD4 Lymphocyte Count; Cephalosporins; Cohort Studies; Colistin; Drug Resistance, Multiple, Bacterial; Dysbiosis; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Feces; HIV Infections; Humans; Intestines; Microbial Sensitivity Tests; Microbiota; Plasmids; Risk Factors; Switzerland | 2017 |